Analyst Ratings January 28, 2026

Goldman Sachs Opens Coverage on Copel With Buy Rating and $10.40 Target

Bank cites sum-of-parts valuation, strong dividend profile and distribution tariff review as key drivers

By Jordan Park ELPC
Goldman Sachs Opens Coverage on Copel With Buy Rating and $10.40 Target
ELPC

Goldman Sachs has started coverage of Copel (NYSE:ELPC) with a Buy recommendation and a $10.40 price target, applying a sum-of-the-parts approach and a 7.4% real WACC. The firm projects robust shareholder returns through elevated dividends and buybacks, and expects more than 20% EBITDA CAGR from 2025 to 2027, driven largely by a distribution tariff review due in June 2026.

Key Points

  • Goldman Sachs initiates coverage on Copel (NYSE:ELPC) with a Buy rating and a $10.40 price target using a sum-of-the-parts valuation and a 7.4% real WACC.
  • The firm forecasts elevated shareholder returns, projecting dividend yields of 8% for 2026 and 10% for 2027, alongside selective NPV-positive growth, including possible participation in a March 2026 reserve auction.
  • Goldman Sachs expects Copel to achieve over 20% EBITDA CAGR from 2025 to 2027, primarily driven by a distribution tariff review scheduled for June 2026; InvestingPro data indicates the stock may be slightly overvalued at a $7.86 billion market cap.

Goldman Sachs has initiated research coverage of Copel (NYSE:ELPC) and assigned a Buy rating with a $10.40 price target, according to a research note released Wednesday. At the time of the note, the stock was trading at $10.62 - marginally below its 52-week high of $10.63 - after gaining 100.79% over the past year.

The bank's valuation is grounded in a sum-of-the-parts framework that applies a 7.4% real weighted average cost of capital (WACC). That valuation underpins Goldman Sachs' expectations for the company, which include stepping up shareholder returns through higher dividends and share repurchases.

Goldman Sachs projects dividend yields of 8% for 2026 and 10% for 2027. The firm also anticipates that Copel will pursue select NPV-positive growth investments and has specifically noted the company may participate in a reserve auction scheduled for March 2026.

On the operational front, Goldman Sachs expects Copel to deliver an EBITDA compound annual growth rate in excess of 20% between 2025 and 2027. The investment bank attributes much of this expected earnings acceleration to a distribution arm tariff review that is slated for June 2026.

Market-data referenced in the note shows Copel's market capitalization at $7.86 billion. According to InvestingPro assessments cited alongside the note, Copel appears slightly overvalued relative to its Fair Value estimate.

Collectively, the valuation approach, the projected dividend trajectory, and the planned or potential growth moves form the basis for Goldman Sachs' Buy recommendation and the $10.40 target. The firm highlights timing-sensitive catalysts - the March 2026 reserve auction and the June 2026 tariff review - as important events tied to its outlook.


Context and implications

The research note combines valuation methodology with event-driven expectations to form a concise forecast for Copel's near-term financial performance and capital return plans. While Goldman Sachs' outlook is bullish enough to justify a Buy rating, InvestingPro data referenced in the note indicates a modest premium to fair value at the company's current market capitalization.

The company-specific catalysts named by Goldman Sachs - a reserve auction and a regulatory tariff review - represent discrete occurrences that the firm expects will materially affect EBITDA and shareholder returns over the 2025-2027 period.

Risks

  • Outcome of the distribution arm tariff review in June 2026 is uncertain and is a key determinant of the projected EBITDA growth - this affects the utilities and energy distribution sector.
  • Participation in the March 2026 reserve auction is presented as a planned growth move, but the execution and NPV outcomes are not guaranteed and could affect capital allocation and shareholder returns.
  • InvestingPro's assessment that Copel appears slightly overvalued relative to Fair Value introduces valuation risk for investors, particularly given the company's current share price and market capitalization.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026